The Duke Clinical Research Institute, funded by a grant from Novartis, is launching a large-scale study to explore the effectiveness of mobile apps in the treatment of heart failure patients. The study, called Connect HF, is aiming to enroll 8,000 patients across 160 hospitals by the end of fall 2018, with results hoped for by the end of 2020.
"CONNECT HF is a clinical trial looking at different...
